Exane BNP Paribas Downgrades MSCI to Underperform, Announces $450 Price Target
Portfolio Pulse from richadhand@benzinga.com
Exane BNP Paribas analyst Arnaud Giblat has downgraded MSCI (NYSE:MSCI) from Neutral to Underperform and set a price target of $450.
July 17, 2023 | 8:52 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
MSCI has been downgraded from Neutral to Underperform by Exane BNP Paribas, with a price target of $450.
The downgrade from Neutral to Underperform by a major analyst like Exane BNP Paribas is likely to negatively impact MSCI's stock in the short term. The price target of $450 may also influence investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100